These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 10231044

  • 1. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 2. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 3. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
    Paiva LC, Pinto-Neto AM, Faundes A.
    Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
    [Abstract] [Full Text] [Related]

  • 4. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
    Petta CA, Faundes A, Dunson TR, Ramos M, DeLucio M, Faundes D, Bahamondes L.
    Fertil Steril; 1998 Feb; 69(2):252-7. PubMed ID: 9496338
    [Abstract] [Full Text] [Related]

  • 5. Long-term depot-medroxyprogesterone acetate and bone mineral density.
    Tang OS, Tang G, Yip P, Li B, Fan S.
    Contraception; 1999 Jan; 59(1):25-9. PubMed ID: 10342083
    [Abstract] [Full Text] [Related]

  • 6. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR.
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
    Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.
    Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
    [Abstract] [Full Text] [Related]

  • 8. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 9. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate.
    Perrotti M, Bahamondes L, Petta C, Castro S.
    Fertil Steril; 2001 Sep; 76(3):469-73. PubMed ID: 11532466
    [Abstract] [Full Text] [Related]

  • 10. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
    Naessen T, Olsson SE, Gudmundson J.
    Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
    [Abstract] [Full Text] [Related]

  • 11. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M, Liblanc M.
    J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
    [Abstract] [Full Text] [Related]

  • 12. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B, Ellis S, Murby B, Randall S, Kirkman R.
    Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
    [Abstract] [Full Text] [Related]

  • 13. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR.
    BMJ; 1991 Jul 06; 303(6793):13-6. PubMed ID: 1830502
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
    Moore LL, Valuck R, McDougall C, Fink W.
    Contraception; 1995 Oct 06; 52(4):215-9. PubMed ID: 8605778
    [Abstract] [Full Text] [Related]

  • 15. Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function.
    Petta CA, Faúndes A, Dunson TR, Ramos M, DeLucio M, Faúndes D, Bahamondes L.
    Fertil Steril; 1998 Nov 06; 70(5):817-20. PubMed ID: 9806559
    [Abstract] [Full Text] [Related]

  • 16. [Status of bone mineral density after the long-standing application of contraception Depo-Provera].
    Zeman S, Havlík P, Zemanová J, Němec D.
    Ceska Gynekol; 2013 Jan 06; 78(1):116-24. PubMed ID: 23607391
    [Abstract] [Full Text] [Related]

  • 17. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L.
    Contraception; 2011 Nov 06; 84(5):e31-7. PubMed ID: 22018135
    [Abstract] [Full Text] [Related]

  • 18. Depo Provera: a profile of current users.
    Jarman H, Kovacs GT, Westcott M.
    Aust N Z J Obstet Gynaecol; 1990 Feb 06; 30(1):74-6. PubMed ID: 2140675
    [Abstract] [Full Text] [Related]

  • 19. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
    Harkins GJ, Davis GD, Dettori J, Hibbert ML, Hoyt RA.
    J Reprod Med; 1999 Mar 06; 44(3):309-12. PubMed ID: 10202754
    [Abstract] [Full Text] [Related]

  • 20. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS, Dalberth BT, Cañamar R, Betz M.
    Contraception; 1997 Nov 06; 56(5):305-12. PubMed ID: 9437559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.